Get the Stockscreener App
0.709
3.26%
-0.0239
After Hours:
.72
0.011
+1.55%
Envoy Medical Inc stock is traded at $0.709, with a volume of 72,445.
It is down -3.26% in the last 24 hours and up +3.01% over the past month.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
See More
Previous Close:
$0.7329
Open:
$0.725
24h Volume:
72,445
Relative Volume:
0.29
Market Cap:
$54.51M
Revenue:
$241.00K
Net Income/Loss:
$-23.76M
P/E Ratio:
-0.5723
EPS:
-1.2389
Net Cash Flow:
$-18.38M
1W Performance:
+9.58%
1M Performance:
+3.01%
6M Performance:
-1.69%
1Y Performance:
-57.42%
1-Day Range:
$0.7002
$0.73
1-Week Range:
$0.645
$0.7675
52-Week Range:
$0.3625
$1.89
Envoy Medical Inc Stock (COCH) Company Profile
Name
Envoy Medical Inc
Sector
Industry
Phone
651-361-8000
Address
4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE
Compare COCH vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COCH
Envoy Medical Inc
|
0.709 | 56.35M | 241.00K | -23.76M | -18.38M | -1.2389 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Envoy Medical Inc Stock (COCH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-26 | Initiated | H.C. Wainwright | Buy |
| Jun-24-24 | Initiated | Ascendiant Capital Markets | Buy |
Envoy Medical Inc Stock (COCH) Latest News
COCH Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive SurpriseLow Estimate Range - Newser
COCH Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Progress, Though Revenue Absence Raises QuestionsHigh Growth Earnings - Newser
Envoy Medical Inc. (COCH) Q1 2026 Earnings: Strong EPS Beat Amidst Pre-Revenue StageEarnings Per Share - Newser
Envoy Medical Q1 2026 Earnings: EPS Surprises to the Upside Despite No Revenue, Stock DeclinesTrading Community Hub - Newser
COCH Q1 2026 Earnings: Significant EPS Beat Amid Revenue UncertaintyElite Trading Signals - Newser
Envoy Medical Granted Extension to Regain Nasdaq Compliance - TipRanks
Envoy Medical Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Envoy Medical (NASDAQ: COCH) granted more time to meet Nasdaq $1 bid rule - Stock Titan
COCH Q1 2026 Earnings: Narrower Loss Beats Estimates as Envoy Medical AdvancesReturn On Assets - Newser
COCH Q1 2026 Earnings: EPS Beats Estimates Despite Pre-Revenue Status, Stock DeclinesShared Buy Zones - Newser
Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology - TMX Newsfile
Envoy Medical shareholders approve plan amendments and board elections at annual meeting By Investing.com - Investing.com South Africa
Envoy Medical shareholders approve plan amendments and board elections at annual meeting - Investing.com Australia
Envoy Medical Shareholders Expand Equity and Governance Plans - TipRanks
Envoy Medical (NASDAQ: COCH) holders back larger equity and stock purchase plans - Stock Titan
Envoy Medical (COCH): Nantahala reports 9.99% position in company - Stock Titan
[SCHEDULE 13G] Envoy Medical, Inc. Passive Investment Disclosure (>5%) - Stock Titan
TradingKey - TradingKey
Envoy Medical Flags Limited Risk Detail, Urges Investors to Review 2026 Form 10-K for Key Uncertainties - TipRanks
ENVOY MEDICAL (COCH) insiders report 2.46M warrants, 3.10% stake - Stock Titan
Envoy Medical, Inc. Q1 2026 Financial Report: Earnings, Balance Sheet, and FDA-Approved Hearing Devices Overview - Minichart
Envoy Medical completes pivotal trial enrollment, raises $78m By Investing.com - Investing.com South Africa
Envoy Medical Achieves Pivotal Trial Milestone and Secures $78M Financing for Fully Implanted Cochlear Implant FDA Approval Progress - Minichart
Envoy Medical completes pivotal trial enrollment, raises $78m - Investing.com
Envoy Medical, Inc. 1Q 2026: Revenue $39K, Net income ($5.7M), EPS ($0.08) — 10-Q Summary - TradingView
Envoy Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Envoy Medical (NASDAQ: COCH) Q1 2026 loss narrows after $27.8M raise - Stock Titan
Envoy Medical reports Q1 2026: $39k revenue, $5.96M operating expenses, $4.35M net loss - TradingView
Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant - marketscreener.com
Envoy Medical (NASDAQ: COCH) boosts cash to $25M as pivotal trial fully enrolls - Stock Titan
56 people get first-of-its-kind fully implanted cochlear implant - Stock Titan
COCHW (Envoy Med) warrant earnings report draws market scrutiny amid limited financial disclosure.Margin Expansion - newser.com
Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio - TMX Newsfile
Envoy Medical Reports on First Quarter 2025 Results - TMX Newsfile
Envoy Medical Corporation and Anzu Special Acquisition Corp I Complete Business Combination - TMX Newsfile
Envoy Medical to Participate in the 37th Annual ROTH Conference - TMX Newsfile
Envoy Medical Reports Third Quarter 2025 Financial and Operational Results - Quantisnow
Envoy Medical's Pivotal Clinical Trial for Fully Implanted Acclaim(R) Cochlear Implant Remains On Track After First Month Follow-Up - TMX Newsfile
Envoy Medical (COCH) Expected to Announce Earnings on Thursday - MarketBeat
Envoy Medical presents early data from cochlear implant trial By Investing.com - Investing.com Nigeria
Envoy Medical presents early data from cochlear implant trial - Investing.com
Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant - Yahoo Finance
Envoy Medical Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant - Florida Hospital News and Healthcare Report
Envoy Med (COCH) Stock Industry Update (Selling Pressure) 2026-04-27Shared Momentum Picks - newser.com
Envoy Medical shares crater after announcing $4 million direct offering - MSN
Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial - TMX Newsfile
COCH (Envoy Medical Inc.) reports Q3 2025 EPS below analyst estimates, as shares rise one percent in daily trading.Special Dividend - Cổng thông tin điện tử tỉnh Tây Ninh
A fully implanted cochlear implant clears key step in 56-patient study - Stock Titan
COCHW | Envoy Medical, Inc Warrant Insider Trading - Quiver Quantitative
Envoy Medical appoints Charles S. McKhann to board of directors By Investing.com - Investing.com India
Envoy Medical Inc Stock (COCH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):